JP2016536332A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536332A5
JP2016536332A5 JP2016539564A JP2016539564A JP2016536332A5 JP 2016536332 A5 JP2016536332 A5 JP 2016536332A5 JP 2016539564 A JP2016539564 A JP 2016539564A JP 2016539564 A JP2016539564 A JP 2016539564A JP 2016536332 A5 JP2016536332 A5 JP 2016536332A5
Authority
JP
Japan
Prior art keywords
seq
chain variable
variable region
antibody
free
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539564A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016536332A (ja
JP6820743B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/069013 external-priority patent/WO2015032932A1/en
Publication of JP2016536332A publication Critical patent/JP2016536332A/ja
Publication of JP2016536332A5 publication Critical patent/JP2016536332A5/ja
Application granted granted Critical
Publication of JP6820743B2 publication Critical patent/JP6820743B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

JP2016539564A 2013-09-05 2014-09-05 炎症性疾患におけるｉｌ−１８結合タンパク質（ｉｌ−１８ｂｐ） Active JP6820743B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13183193.5 2013-09-05
EP13183193 2013-09-05
PCT/EP2014/069013 WO2015032932A1 (en) 2013-09-05 2014-09-05 Il-18 binding protein (il-18bp) in inflammatory diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019210436A Division JP2020055821A (ja) 2013-09-05 2019-11-21 炎症性疾患におけるｉｌ−１８結合タンパク質（ｉｌ−１８ｂｐ）

Publications (3)

Publication Number Publication Date
JP2016536332A JP2016536332A (ja) 2016-11-24
JP2016536332A5 true JP2016536332A5 (https=) 2017-08-10
JP6820743B2 JP6820743B2 (ja) 2021-01-27

Family

ID=49111035

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016539564A Active JP6820743B2 (ja) 2013-09-05 2014-09-05 炎症性疾患におけるｉｌ−１８結合タンパク質（ｉｌ−１８ｂｐ）
JP2019210436A Pending JP2020055821A (ja) 2013-09-05 2019-11-21 炎症性疾患におけるｉｌ−１８結合タンパク質（ｉｌ−１８ｂｐ）

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019210436A Pending JP2020055821A (ja) 2013-09-05 2019-11-21 炎症性疾患におけるｉｌ−１８結合タンパク質（ｉｌ−１８ｂｐ）

Country Status (23)

Country Link
US (3) US10858426B2 (https=)
EP (2) EP3978526A1 (https=)
JP (2) JP6820743B2 (https=)
KR (2) KR102512797B1 (https=)
CN (2) CN115925928A (https=)
AU (1) AU2014317035B2 (https=)
CL (1) CL2016000506A1 (https=)
CY (1) CY1124698T1 (https=)
DK (1) DK3041864T3 (https=)
ES (1) ES2892923T3 (https=)
HU (1) HUE055608T2 (https=)
IL (1) IL244169B (https=)
LT (1) LT3041864T (https=)
MX (1) MX385868B (https=)
NZ (1) NZ717671A (https=)
PH (1) PH12016500425B1 (https=)
PL (1) PL3041864T3 (https=)
PT (1) PT3041864T (https=)
RU (1) RU2731713C2 (https=)
SG (1) SG11201601717VA (https=)
SI (1) SI3041864T1 (https=)
UA (1) UA125204C2 (https=)
WO (1) WO2015032932A1 (https=)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115925928A (zh) 2013-09-05 2023-04-07 Ab2生物股份有限公司 炎性疾病中的il-18结合蛋白(il-18bp)
US10882905B2 (en) * 2015-03-05 2021-01-05 Ab2 Bio Sa IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases
US20180362660A1 (en) * 2016-05-09 2018-12-20 Schickwann Tsai Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
GB201614455D0 (en) 2016-08-24 2016-10-05 Univ Oxford Innovation Ltd Biomarkers
DE102016219607B4 (de) * 2016-10-10 2025-04-30 Siemens Healthineers Ag Erzeugung einer mit anatomischen Bilddaten korrelierten Ergebniskarte
WO2019133799A1 (en) * 2017-12-29 2019-07-04 University Of Florida Research Foundation Monoclonal antibodies targeting microtubule-binding domain of tau protein
TWI679279B (zh) * 2018-05-09 2019-12-11 臺中榮民總醫院 檢測成人發作型史笛兒氏症之罹病風險及預後之方法
CA3104362A1 (en) 2018-06-19 2019-12-26 Shanghaitech University Human antibodies to human interleukin 18 receptor alpha and beta
US12269874B2 (en) 2018-12-03 2025-04-08 mAbProtein Co., Ltd. Antibody that recognizes neoepitope of activated interleukin-18 proteins and application thereof
CN110433289B (zh) * 2019-09-10 2024-12-17 中山大学附属口腔医院 用于治疗牙周致病菌感染引起的牙周膜细胞功能紊乱与牙槽骨丧失的药物
IL292443A (en) * 2019-11-04 2022-06-01 Medimmune Ltd Methods for using IL-33 antagonists
US20230173021A1 (en) * 2020-05-06 2023-06-08 Ab2 Bio Sa IL-18 Binding Protein (IL-18BP) In Respiratory Diseases
GB202007404D0 (en) * 2020-05-19 2020-07-01 Nasser Syed Muhammad Tahir Treatment for viral respiratory infections
EP4178614A4 (en) * 2020-07-08 2024-10-30 Georgia Tech Research Corporation COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF SARS-COV-2 VIRUS INFECTIONS
EP3943097A1 (en) 2020-07-24 2022-01-26 AB2 Bio SA Car-t cell therapy
KR20220044057A (ko) * 2020-09-29 2022-04-06 주식회사 에이프릴바이오 인터루킨-18 결합 단백질 및 혈청 알부민에 대한 항원 결합 단편을 포함하는 융합 단백질, 및 이의 용도
JP2023549257A (ja) 2020-11-18 2023-11-22 ノバルティス アーゲー Ｎｌｒｃ４－ｇｏｆインフラマソーム病の処置における使用のための二特異性抗体
WO2022109340A1 (en) * 2020-11-20 2022-05-27 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Immunomodulatory clinical biomarker profiles and uses thereof
EP4371573A4 (en) 2021-07-13 2025-08-20 National Univ Corporation Tokai National Higher Education And Research System MEDICINAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
WO2023067348A1 (en) * 2021-10-21 2023-04-27 Biosirius Ltd Treatment for virally-induced pneumonia
CN114236139A (zh) * 2021-12-30 2022-03-25 苏州和锐生物科技有限公司 一种TNF-α生物制剂的抗体检测试剂盒、制备方法
CA3244428A1 (en) 2022-03-04 2023-09-07 Ab2 Bio Sa IL-18 BINDING PROTEIN (IL-18BP) IN THE TREATMENT OF VEXAS SYNDROME
IL321948A (en) 2023-01-06 2025-09-01 Lassen Therapeutics Inc Anti-IL-18 BP antibodies
EP4646270A2 (en) 2023-01-06 2025-11-12 Alector LLC Anti-il18 binding protein antibodies and methods of use thereof
TW202434634A (zh) * 2023-02-20 2024-09-01 大陸商瑞石生物醫藥有限公司 抗IL-18Rβ抗體、其抗原結合片段及其醫藥應用
AU2024238511A1 (en) * 2023-03-21 2025-10-02 Coya Therapeutics, Inc. Biomarkers of amyotrophic lateral sclerosis and uses thereof
WO2025253161A1 (en) * 2024-06-05 2025-12-11 Aprilbio Co., Ltd. Methods for treating liver diseases using recombinant fusion proteins comprising interleukin-18-binding protein and antigen binding fragment to serum albumin
WO2026038145A1 (en) 2024-08-13 2026-02-19 Ab2 Bio Sa Il-18 binding protein (il-18bp) and methods of using same

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9014932D0 (en) 1990-07-05 1990-08-22 Celltech Ltd Recombinant dna product and method
ATE190629T1 (de) 1991-01-18 2000-04-15 Amgen Inc Methoden zur behandlung von durch den tumor nekrose faktor ausgelösten krankheiten
WO1994004679A1 (en) 1991-06-14 1994-03-03 Genentech, Inc. Method for making humanized antibodies
JPH05244982A (ja) 1991-12-06 1993-09-24 Sumitomo Chem Co Ltd 擬人化ｂ−ｂ１０
US5635599A (en) 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands
WO1996013590A2 (en) 1994-10-21 1996-05-09 Innogenetics N.V. New sequences of hepatitis c virus genotypes and their use as prophylactic, therapeutic and diagnostic agents
US5756662A (en) 1995-03-14 1998-05-26 Corixa Corporation Compounds and methods for the detection of T. cruzi infection
US7220717B2 (en) 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
IL121860A0 (en) 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
TWI335336B (https=) 2000-02-10 2011-01-01 Abbott Gmbh & Co Kg
NZ520122A (en) * 2000-02-21 2005-04-29 Applied Research Systems Use of IL-18 inhibitors
EE05056B1 (et) 2000-05-05 2008-08-15 Applied Research Systems Ars Holding N.V. IL-18 inhibiitorite kasutamine ravimi valmistamiseks, mis on ette n„htud ateroskleroosi ravimiseks ja/v?i ennetamiseks
US20040198706A1 (en) 2003-03-11 2004-10-07 Carrara Dario Norberto R. Methods and formulations for transdermal or transmucosal application of active agents
EA013564B1 (ru) 2000-08-03 2010-06-30 Терапеутик Хьюман Поликлоналз Инк. Гуманизированный иммуноглобулин и содержащая его фармацевтическая композиция
AU2002224417A1 (en) 2000-10-18 2002-04-29 Immunex Corporation Methods for treating il-18 mediated disorders
HU229164B1 (en) * 2001-01-29 2013-09-30 Serono Sa Coinsins Lab Use of il-18 inhibitors for the treatment and/or prevention of heart disease
ES2334773T3 (es) * 2001-05-16 2010-03-16 Yeda Research And Development Co. Ltd. Uso de inhibidores de il-18 para el tratamiento o prevencion de la sepsis.
PL216228B1 (pl) 2001-05-25 2014-03-31 Ares Trading Sa Zastosowanie białka wiążącego IL-18
GB0300531D0 (en) 2003-01-10 2003-02-12 West Pharm Serv Drug Res Ltd Pharmaceutical compositions
US20080076708A1 (en) * 2003-05-13 2008-03-27 Valter Altarocca Active Variants of the Il-18 Binding Protein and Medical Uses Thereof
US20050100965A1 (en) 2003-11-12 2005-05-12 Tariq Ghayur IL-18 binding proteins
AU2011224023C1 (en) 2003-11-12 2013-08-29 Abbvie Inc. IL-18 binding proteins
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
WO2005087249A1 (ja) 2004-03-11 2005-09-22 Kurume University プロテアーゼ阻害剤及び疾患の予防又は治療剤
CA2572921C (en) 2004-07-09 2017-01-03 The University Of North Carolina At Chapel Hill Replication-competent and propagation-defective venezuelan equine encephalitis (vee) viral adjuvants
EP1793859B1 (en) 2004-08-20 2009-03-25 Smithkline Beecham Corporation Treatment of oral and intestinal mucositis by administering human il-18
EP2267024B1 (en) 2005-06-03 2012-05-09 Ares Trading S.A. Production of recombinant Il-18 binding protein
US7612181B2 (en) 2005-08-19 2009-11-03 Abbott Laboratories Dual variable domain immunoglobulin and uses thereof
DE602006021038D1 (de) 2005-09-15 2011-05-12 Univ Mcgill Verfahren zur diagnose eines ovarialkarzinoms
WO2008091592A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
CA2691039A1 (en) 2007-05-29 2008-12-11 Yale University Il-18 and protein kinase r inhibition for the treatment of copd
KR20140003467A (ko) * 2010-12-20 2014-01-09 메디뮨 리미티드 항il-18 항체 및 그의 용도
US9376489B2 (en) * 2012-09-07 2016-06-28 Novartis Ag IL-18 binding molecules
CN115925928A (zh) 2013-09-05 2023-04-07 Ab2生物股份有限公司 炎性疾病中的il-18结合蛋白(il-18bp)
US10882905B2 (en) * 2015-03-05 2021-01-05 Ab2 Bio Sa IL-18 binding protein (IL-18BP) and antibodies in inflammatory diseases

Similar Documents

Publication Publication Date Title
JP2016536332A5 (https=)
US20230250164A1 (en) IL-18 Binding Protein (IL-18BP) In Inflammatory Diseases
JP2018513116A5 (https=)
JP2020019781A (ja) 抗ｉｌ−５抗体を投与するための方法
JP2019065029A (ja) 処置方法
RU2017134857A (ru) Il-18-связывающие белок (il-18bp) и антитела при воспалительных заболеваниях
US20220151581A1 (en) Methods for treating idiopathic pulmonary fibrosis
JP2017537105A (ja) 瘻孔を伴うクローン病の治療用ベドリズマブ
JP2024521638A (ja) 好酸球トラップの阻害
CN108431039B (zh) 改进的p2x7受体结合剂和包含其的多肽
KR102523019B1 (ko) 항-a베타 항체 및 이의 용도
JP2025069136A (ja) 線維性疾患の治療のための抗エフリン－ｂ２遮断抗体
JP6351828B2 (ja) 肝細胞癌の抗ｖｅｇｆｒ２抗体治療
WO2019014768A1 (en) ANTI-BETA-AMYLOID ANTIBODY
US20230091430A1 (en) TREATMENT OF ATOPIC DERMATITIS EMPLOYING ANTI-IL-13Ra1 ANTIBODY OR BINDING FRAGMENT THEREOF IN AN ALLERGIC POPULATION
JP2024529809A (ja) アレルギー体質の個体群における抗ＩＬ－１３Ｒα１抗体またはその結合フラグメントを使用するアトピー性皮膚炎の処置
WO2024204745A1 (ja) 間質性肺疾患の治療薬
WO2025120567A1 (en) Method of treatment of asthma
TW202508591A (zh) 癌症治療
WO2026041740A1 (en) Treatment of high-risk asthma by blocking il-13 and tslp
JP2024107313A (ja) 肺、腎臓、または肝臓の線維症疾患の処置に使用するためのｐｓｍｐアンタゴニスト
TH1701005048A (th) โปรตีนเข้าจับ il-18 (il-18bp) และ แอนติบอดีในโรคที่มีการอักเสบ
JPWO2022040461A5 (https=)
HK1221726B (en) Il-18 binding protein (il-18bp) in inflammatory diseases